ATE532064T1 - Genmarker und dessen verwendung - Google Patents
Genmarker und dessen verwendungInfo
- Publication number
- ATE532064T1 ATE532064T1 AT06702618T AT06702618T ATE532064T1 AT E532064 T1 ATE532064 T1 AT E532064T1 AT 06702618 T AT06702618 T AT 06702618T AT 06702618 T AT06702618 T AT 06702618T AT E532064 T1 ATE532064 T1 AT E532064T1
- Authority
- AT
- Austria
- Prior art keywords
- immunosuppressive agent
- rejection
- immunological tolerance
- efficacy
- absence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005006728 | 2005-01-13 | ||
| JP2006000336 | 2006-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE532064T1 true ATE532064T1 (de) | 2011-11-15 |
Family
ID=40789099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06702618T ATE532064T1 (de) | 2005-01-13 | 2006-01-13 | Genmarker und dessen verwendung |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US20090162868A1 (de) |
| AT (1) | ATE532064T1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2752766C1 (ru) * | 2020-11-10 | 2021-08-03 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" | Способ определения иммунологической толерантности у животных |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
-
2006
- 2006-01-13 US US11/795,225 patent/US20090162868A1/en not_active Abandoned
- 2006-01-13 AT AT06702618T patent/ATE532064T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| US20090162868A1 (en) | 2009-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ592358A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2) | |
| EP1996718A4 (de) | Toxizitätsscreeningverfahren | |
| BR112012019542A2 (pt) | "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit" | |
| IL183872A (en) | Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders | |
| ATE534911T1 (de) | Verfahren zur diagnostizierung einer entzündlichen darmerkrankung | |
| WO2012024255A3 (en) | Camkk-beta as a target for treating cancer | |
| NZ592365A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| ATE548467T1 (de) | Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände | |
| MX2015006680A (es) | Composiciones y metodos para diagnosticar tumores de tiroides. | |
| NZ610356A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| ATE493649T1 (de) | Verfahren zur diagnose von polyzystischer nierenkrankheit | |
| IN2014DN04226A (de) | ||
| BR112013000869A2 (pt) | método para diagnóstico de câncer de próstata (pca) com uma sensibilidade desejada em um sujeito; método para monitorar a progressão do câncer de próstata (pca) em um sujeito; método para avaliar se um sujeito tem que ser submetido a uma biópsia de próstata; kit compreendendo um primeiro componente e, opcionalmente, um segundo componente e uso de um kit | |
| IN2013CN01129A (de) | ||
| WO2008091814A3 (en) | Assessment of asthma and allergen-dependent gene expression | |
| EA201490384A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| EP2021794B8 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| ATE521894T1 (de) | Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex | |
| RU2014105558A (ru) | Диагностика болезни альцгеймера | |
| WO2006001931A3 (en) | Prouroguanylin as therapeutic and diagnostic agents | |
| WO2008131261A3 (en) | Peptide biomarkers of cardiovascular disease | |
| WO2020163581A8 (en) | Markers for the diagnosis of biochemical recurrence in prostate cancer | |
| ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| WO2018065118A3 (en) | Method and analysis system for testing a sample | |
| EP1767652A4 (de) | Genmarker und dessen verwendung |